Financial Architects (New Jersey)’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,460
Closed -$352K 111
2022
Q1
$352K Sell
6,460
-476
-7% -$25.9K 0.05% 238
2021
Q4
$382K Buy
6,936
+5
+0.1% +$275 0.05% 239
2021
Q3
$331K Buy
6,931
+3
+0% +$143 0.05% 250
2021
Q2
$345K Buy
6,928
+4
+0.1% +$199 0.05% 244
2021
Q1
$309K Sell
6,924
-136
-2% -$6.07K 0.05% 252
2020
Q4
$325K Buy
7,060
+242
+4% +$11.1K 0.06% 215
2020
Q3
$321K Buy
6,818
+4
+0.1% +$188 0.07% 191
2020
Q2
$347K Sell
6,814
-120
-2% -$6.11K 0.08% 170
2020
Q1
$328K Buy
6,934
+327
+5% +$15.5K 0.09% 159
2019
Q4
$388K Buy
6,607
+182
+3% +$10.7K 0.08% 168
2019
Q3
$343K Buy
6,425
+83
+1% +$4.43K 0.08% 175
2019
Q2
$317K Sell
6,342
-218
-3% -$10.9K 0.06% 193
2019
Q1
$343K Sell
6,560
-1,446
-18% -$75.6K 0.06% 210
2018
Q4
$382K Sell
8,006
-1,208
-13% -$57.6K 0.07% 175
2018
Q3
$463K Sell
9,214
-321
-3% -$16.1K 0.08% 171
2018
Q2
$481K Sell
9,535
-482
-5% -$24.3K 0.09% 166
2018
Q1
$489K Buy
10,017
+2,579
+35% +$126K 0.1% 151
2017
Q4
$330K Sell
7,438
-2,107
-22% -$93.5K 0.06% 212
2017
Q3
$485K Sell
9,545
-8
-0.1% -$406 0.09% 157
2017
Q2
$515K Sell
9,553
-314
-3% -$16.9K 0.09% 142
2017
Q1
$520K Buy
9,867
+393
+4% +$20.7K 0.09% 148
2016
Q4
$456K Sell
9,474
-576
-6% -$27.7K 0.11% 151
2016
Q3
$541K Buy
10,050
+970
+11% +$52.2K 0.15% 126
2016
Q2
$492K Buy
9,080
+1,770
+24% +$95.9K 0.14% 130
2016
Q1
$371K Sell
7,310
-1,336
-15% -$67.8K 0.13% 125
2015
Q4
$424K Buy
8,646
+1,314
+18% +$64.4K 0.17% 125
2015
Q3
$352K Buy
7,332
+1,260
+21% +$60.5K 0.15% 136
2015
Q2
$316K Buy
+6,072
New +$316K 0.11% 137
2015
Q1
Sell
-2,358
Closed -$126K 954
2014
Q4
$126K Buy
2,358
+1,062
+82% +$56.7K 0.06% 222
2014
Q3
$74K Sell
1,296
-246
-16% -$14K 0.04% 265
2014
Q2
$103K Buy
+1,542
New +$103K 0.05% 220
2013
Q4
Sell
-1,136
Closed -$73K 322
2013
Q3
$73K Buy
1,136
+217
+24% +$13.9K 0.05% 215
2013
Q2
$58K Buy
+919
New +$58K 0.04% 227